1. Surface transmission. Researchers at Australia’s national science agency, CSIRO, found evidence that SARS-CoV-2 — the virus that causes COVID-19 — can survive on common surfaces for up to 28 days. The study results were published Oct. 12 in Virology Journal.
2. Reinfection. The first confirmed cases of COVID-19 reinfection in the U.S. were reported in a 25-year-old Nevada man and a 42-year-old Virginia man, Medscape reported Oct. 12. Two months after testing positive for the first time, both men were reinfected with slightly different strains, gene tests showed.
3. Vaccines. Johnson & Johnson voluntarily paused the clinical trial for its COVID-19 vaccine candidate Oct. 12 after learning of a participant’s unexplained illness. In September, AstraZeneca took a “voluntary pause” of its phase 3 COVID-19 vaccine trial after an adverse reaction in a patient in the U.K.
More articles on surgery centers:
The 3 things facilities should do now to prepare for the 2021 CMS Physician Fee Schedule
6 must-know coding updates in 2020
Blue Cross North Carolina, Wake Forest collaborate on new insurance network
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
